Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
16.59
Oct 30 • 3:59 PM ET Dollar change-0.31 Percentage change(-1.83%)
Aftermarket Close
16.46
Aftermarket • 7:45 PM ET Dollar change-0.13 Percentage change(-0.78%)
Oct 29, 7:43 PMHercules posts solid Q3 NII of $0.47 per share, guides to higher Q4 income on rebounding prepays
Index
-
Market Cap
3.14B
Enterprise Value
5.66B
Income
353.73M
Sales
593.68M
Book/sh
12.26
Cash/sh
0.27
Employees
100
IPO
Jun 09, 2005
P/E
9.10
Forward P/E
8.53
PEG
7.61
P/S
5.30
P/B
1.35
P/C
62.20
P/FCF
9.85
EV/EBITDA
12.07
EV/Sales
9.53
Quick Ratio
0.21
Current Ratio
0.21
Debt/Eq
1.10
LT Debt/Eq
0.95
Option/Short
Yes / Yes
EPS (ttm)
1.82
EPS next Y
1.95
EPS next Q
0.48
EPS this Y
0.23%
EPS next Y
1.11%
EPS next 5Y
1.12%
EPS past 3/5Y
32.98% -1.60%
Sales past 3/5Y
14.88% 16.30%
EPS Y/Y TTM
9.28%
Sales Y/Y TTM
40.48%
EPS Q/Q
-26.64%
Sales Q/Q
1.36%
Insider Own
1.95%
Insider Trans
0.00%
Inst Own
34.79%
Inst Trans
-
ROA
7.56%
ROE
15.67%
ROIC
7.79%
Gross Margin
97.95%
Oper. Margin
78.94%
Profit Margin
59.58%
SMA20
0.67%
SMA50
-2.47%
SMA200
3.22%
Trades
Shs Outstand
189.60M
Shs Float
183.52M
52W High
18.88 -12.13%
52W Low
13.58 22.13%
Volatility
1.56% 1.69%
ATR (14)
0.29
RSI (14)
48.81
Beta
0.77
Rel Volume
1.59
Avg Volume
1.39M
Volume
2,204,878
Perf Week
1.10%
Perf Month
-2.07%
Perf Quarter
-0.90%
Perf Half Y
2.65%
Perf YTD
-10.68%
Perf Year
-4.06%
Perf 3Y
14.39%
Perf 5Y
4.55%
Perf 10Y
34.81%
Prev Close
16.90
Price
16.59
Change %
-1.83%
Consensus
Strong Buy
Avg. Price Target
$19.50
Implied Upside
+17.5%
Analysts8incl. previous ratings
Rating Distribution6 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 01, 2026Upgrade
UBS logoUUBS
Neutral → Buy$18.50+11.5%
Feb 13, 2026Downgrade
PPiper Sandler
Overweight → Neutral$17.50+5.5%
Nov 04, 2025Upgrade
CCompass Point
Neutral → Buy$19.50+17.5%
Dec 12, 2024Upgrade
KKeefe Bruyette
Mkt Perform → Outperform$19.50 → $21.50+29.6%
Jan 16, 2024Downgrade
CCompass Point
Buy → Neutral$17 → $17.50+5.5%
Nov 21, 2023Initiated
UBS logoUUBS
Neutral$17+2.5%
Aug 30, 2023Upgrade
CCompass Point
Neutral → Buy$17.50+5.5%
Aug 04, 2023Upgrade
KKeefe Bruyette
Underperform → Mkt Perform$13.50 → $17+2.5%
Apr 06, 2023Upgrade
PPiper Sandler
Neutral → Overweight$16-3.6%
Mar 13, 2023Downgrade
KKeefe Bruyette
Mkt Perform → Underperform$14.50 → $10.50-36.7%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BADAVAS ROBERT PDirectorMar 26 '26Buy14.353,65852,4925,070Mar 30 07:55 PM
Loo WadeDirectorMar 26 '26Buy14.357,317104,99914,050Mar 30 07:46 PM
Fallon Thomas JDirectorMar 26 '26Buy14.307,300104,390157,669Mar 30 07:45 PM
Aguirre DeAnneDirectorMar 26 '26Buy14.357,317104,99910,749Mar 30 03:56 PM
Randhawa Paramjeet KDirectorMar 26 '26Buy14.352,92641,98822,486Mar 30 03:40 PM
CROWELL GAYLE ADirectorMar 26 '26Buy14.357,317104,99997,589Mar 30 03:38 PM
Theodosopoulos NikosDirectorMar 26 '26Buy14.357,317104,99929,362Mar 30 03:37 PM
Randhawa Paramjeet KDirectorMar 04 '26Buy14.783,05045,07919,560Mar 05 02:54 PM
Theodosopoulos NikosDirectorFeb 27 '26Buy14.212,60036,94621,523Feb 27 05:22 PM
BADAVAS ROBERT PDirectorFeb 27 '26Buy14.275,00071,350122,073Feb 27 04:53 PM
Botelho Kiersten ZazaChief Legal Officer & CCOFeb 27 '26Buy14.211,30018,47393,336Feb 27 04:34 PM
Fallon Thomas JDirectorFeb 27 '26Buy14.2020,000284,000150,369Feb 27 04:33 PM
Meyer Seth HChief Financial OfficerFeb 27 '26Buy14.337,000100,310448,553Feb 27 04:33 PM
Bluestein ScottChief Executive OfficerFeb 27 '26Buy14.357,000100,4502,516,379Feb 27 04:33 PM
Loo WadeDirectorFeb 25 '26Buy14.983,30049,43432,767Feb 26 04:24 PM
BADAVAS ROBERT PDirectorFeb 24 '26Buy15.015,00075,050117,073Feb 25 08:53 PM
Fallon Thomas JDirectorFeb 24 '26Buy14.9810,000149,800130,369Feb 25 04:03 PM
CROWELL GAYLE ADirectorFeb 23 '26Buy15.206,600100,32087,458Feb 25 08:59 AM
Bluestein ScottChief Executive OfficerFeb 24 '26Buy15.0830,000452,4002,509,379Feb 24 06:53 PM
Theodosopoulos NikosDirectorFeb 17 '26Buy15.936,16598,20818,923Feb 19 11:13 AM
Fallon Thomas JDirectorFeb 17 '26Buy15.8820,000317,600120,369Feb 19 11:12 AM
CROWELL GAYLE ADirectorNov 03 '25Buy17.776,000106,64778,727Nov 04 05:32 PM
Hercules Capital, Inc. is a business development company. It focuses on venture lending capital-backed companies in the technology and life science industries. The company was founded in December 2003 and is headquartered in San Mater, CA.
CEOMr. Scott Bluestein
PresidentMr. Seth Hardy Meyer
Chief Operating OfficerMr. Christian Follmann
Chief Legal OfficerMs. Kiersten Zaza Botelho
CPAMr. Andrew Jordan Olson C.F.A.